Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography-Reference-Cited by-同舟云学术

Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography

Published:2008 Issue:3 Volume:23 Page:243-254
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol. Clin. Exp.

Author:

Anderer Peter,Saletu Bernd,Wolzt Michael,Culic Svetlana,Assandri Alessandro,Nannipieri Fabrizio,Rosini Sergio,Saletu-Zyhlarz Gerda M.

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Reference36 articles.

1. Abiogen Pharma SpA. 2001. Abio 08/01 – Investigator's brochure.

2. Planning controlled clinical trials on the basis of descriptive data analysis

3. Differential effects of normal aging on sources of standard N1, target N1 and target P300 auditory event-related brain potentials revealed by low resolution electromagnetic tomography (LORETA)

4. Non-invasive localization of P300 sources in normal aging and age-associated memory impairment

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of multiple comparison correction procedures in drug assessment studies using LORETA maps;Medical & Biological Engineering & Computing;2015-06-04

2. Novel investigational therapeutics for panic disorder;Expert Opinion on Investigational Drugs;2014-12-24

3. Frontal-parietal responses to “oddball” stimuli depicting “fattened” faces are increased in successful dieters: An electroencephalographic study;International Journal of Psychophysiology;2011-11

4. Cognitive effects of topiramate revealed by standardised low-resolution brain electromagnetic tomography (sLORETA) of event-related potentials;Clinical Neurophysiology;2010-09

5. Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Study on the Pharmacodynamics of ABIO-08/01, a New CNS Drug with Potential Anxiolytic Activity;Neuropsychobiology;2009